Scarica l'app Stockscreener
1.73
1.70%
-0.03
Pre-mercato:
1.73
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
BDTX|Black Diamond Therapeutics Inc|Price:1.730|Chg%:-0.030 - TradingKey
Black Diamond Therapeutics (BDTX): BlackRock discloses 3.84M-share, 6.7% ownership - Stock Titan
Black Diamond Therapeutics, Inc. Revenue Breakdown – NASDAQ:BDTX - TradingView
Black Diamond Therapeutics Inc (BDTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BDTX|Black Diamond Therapeutics Inc|Price:1.760|Chg%:-0.080 - TradingKey
Black Diamond Therapeutics Inc (BDTX) Balance Sheet - TradingKey
Black Diamond Therapeutics Inc (BDTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Black Diamond Therapeutics Inc (BDTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BLACK DIAMOND THERAPEUTICS I (BDTX) Stock Price & Overview - ChartMill
Black Diamond Therapeutics (BDTX) 24th Annual Needham Virtual Healthcare Conference summary - Quartr
Black Diamond Therapeutics (BDTX) Edges Higher Amid Key Support TestSeasonality Effect - dars.gov.et
BDTX Q1 2026 Earnings: Narrowed Loss Beats Estimates as Development Progress ContinuesConsensus Beat Rate - dars.gov.et
T. Rowe Price (BDTX) lists 4.03M shares, 7.0% stake in amendment - Stock Titan
Black Diamond Therapeutics: Positive Phase 2 Results Offer An Upside (NASDAQ:BDTX) - Seeking Alpha
BDTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BDTX SEC FilingsBlack Diamond Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali - Moomoo
Black Diamond Therapeutics touts Silevertinib lung cancer data, eyes FDA path - MSN
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash - Moomoo
Black Diamond Therapeutics 2026 Annual Stockholder Meeting Results and Voting Outcomes - Minichart
Form 4 Black Diamond Therapeutics Inc For: 29 June By Investing.com - Investing.com Nigeria
[Form 4] Black Diamond Therapeutics, Inc. Insider Trading Activity - Stock Titan
Black Diamond (BDTX) director awarded 40,000 stock options at $1.71 - Stock Titan
Black Diamond Therapeutics (BDTX) director awarded 40,000 stock options at $1.71 - Stock Titan
Director Garry Menzel granted 40,000 BDTX stock options at $1.71 strike - Stock Titan
Black Diamond (NASDAQ: BDTX) director receives 40,000 stock options at $1.71 - Stock Titan
Black Diamond Therapeutics (BDTX) awards 40,000-share option grant - Stock Titan
Black Diamond Therapeutics (BDTX) 2026 meeting backs directors, auditor and annual say-on-pay - Stock Titan
Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) added to Russell 2000 Index - marketscreener.com
Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark - marketscreener.com
Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) added to Russell 3000E Index - marketscreener.com
Enterprise value to EBITDA forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView
Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell Small Cap Completeness Index - marketscreener.com
Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2500 Value Benchmark - marketscreener.com
Black Diamond Therapeutics (BDTX) AGM 2026 Summary - Quartr
Price to sales forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView
Price to book forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView
Black Diamond Therapeutics, Inc. Actuals & Estimates (NASDAQ:BDTX) - TradingView
Enterprise value to EBIT forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView
Price to earnings forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView
Price to sales forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView
Enterprise value to revenue forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView
BDTX shares gain 11% in a week: Here's what you should know - MSN
BDTX Forecast — Price Target — Prediction for 2027 - TradingView
Black Diamond Therapeutics (BDTX) Rallies 3.11%: Testing Key Resistance at $1.74Moving Average Ribbon - DonanımHaber
Form 4 Black Diamond Therapeutics Inc For: 22 June By Investing.com - Investing.com Nigeria
Ali Behbahani of Black Diamond (NASDAQ: BDTX) receives 8,961-share award - Stock Titan
Black Diamond Therapeutics Inc (BDTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Black Diamond Therapeutics Inc (BDTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Black Diamond Therapeutics Inc - TradingKey
Black Diamond Therapeutics Inc (BDTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):